DIN 02481332 — ORILISSA 150 MG
ORILISSA is a tablet of Elagolix marketed by ABBVIE CORPORATION. The full Elagolix monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02481332
- Brand name
- ORILISSA
- Active ingredient
- Elagolix
- Strength
- 150 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Gonadotropin-releasing hormone (GnRH) receptor antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Elagolix products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02481340 | ORILISSA | 200 MG | TABLET | ABBVIE CORPORATION | MARKETED |